NO20073850L - Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat - Google Patents

Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat

Info

Publication number: NO20073850L
Authority: NO; Norway
Prior art keywords: terbutaline sulfate; controlled release; polymeric composition; release delivery; derivative
Prior art date: 2005-01-19

Application number

NO20073850A

Other languages

English (en)

Norwegian (no)

Inventor

Adnan Badwan

Mayyas Al-Remawi

Original Assignee

Jordanian Pharmaceutical Mfg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-01-19

Filing date

2007-07-23

Publication date

2007-10-10

2007-07-23 Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg

2007-10-10 Publication of NO20073850L publication Critical patent/NO20073850L/no

Links

239000000203 mixture Substances 0.000 title abstract 5
229960005105 terbutaline sulfate Drugs 0.000 title abstract 3
KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 title abstract 3
238000013270 controlled release Methods 0.000 title abstract 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
239000011159 matrix material Substances 0.000 abstract 2
229920001285 xanthan gum Polymers 0.000 abstract 2
229940082509 xanthan gum Drugs 0.000 abstract 2
235000010493 xanthan gum Nutrition 0.000 abstract 2
239000000230 xanthan gum Substances 0.000 abstract 2
229920001661 Chitosan Polymers 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1
229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20073850A 2005-01-19 2007-07-23 Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat NO20073850L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05000985A EP1685831B1 (en)	2005-01-19	2005-01-19	Pharmaceutical polymer composition for oral controlled release delivery of terbutaline sulfate
PCT/EP2005/013530 WO2006076951A1 (en)	2005-01-19	2005-12-29	Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate

Publications (1)

Publication Number	Publication Date
NO20073850L true NO20073850L (no)	2007-10-10

Family

ID=34933362

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20073850A NO20073850L (no)	2005-01-19	2007-07-23	Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat

Country Status (13)

Country	Link
US (1)	US20080206334A1 (pt)
EP (2)	EP1685831B1 (pt)
KR (1)	KR20070100364A (pt)
CN (1)	CN101102756A (pt)
AT (1)	ATE355833T1 (pt)
BR (1)	BRPI0519622A2 (pt)
CA (1)	CA2592269A1 (pt)
DE (1)	DE602005000675T2 (pt)
EA (1)	EA013969B1 (pt)
ES (1)	ES2284088T3 (pt)
NO (1)	NO20073850L (pt)
WO (1)	WO2006076951A1 (pt)
ZA (1)	ZA200705660B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011031620A1 (en) *	2009-09-11	2011-03-17	Transtech Pharma, Inc.	Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same
CN102188399B (zh) *	2011-04-02	2012-12-12	南京正科制药有限公司	托拉塞米胃漂浮片及其制备方法
CN110057932B (zh) *	2019-04-22	2022-03-15	上海旭东海普药业有限公司	高效液相色谱分析硫酸特布他林有关物质的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0187703B1 (en) *	1985-01-11	1992-08-05	Teijin Limited	Sustained release preparation
US5620706A (en) *	1995-04-10	1997-04-15	Universite De Sherbrooke	Polyionic insoluble hydrogels comprising xanthan and chitosan

2005
- 2005-01-19 ES ES05000985T patent/ES2284088T3/es not_active Expired - Lifetime
- 2005-01-19 AT AT05000985T patent/ATE355833T1/de not_active IP Right Cessation
- 2005-01-19 EP EP05000985A patent/EP1685831B1/en not_active Expired - Lifetime
- 2005-01-19 DE DE602005000675T patent/DE602005000675T2/de not_active Expired - Lifetime
- 2005-12-29 EP EP05820497A patent/EP1838299A1/en not_active Withdrawn
- 2005-12-29 US US11/813,301 patent/US20080206334A1/en not_active Abandoned
- 2005-12-29 KR KR1020077018762A patent/KR20070100364A/ko not_active Ceased
- 2005-12-29 CN CNA2005800468260A patent/CN101102756A/zh active Pending
- 2005-12-29 ZA ZA200705660A patent/ZA200705660B/xx unknown
- 2005-12-29 CA CA002592269A patent/CA2592269A1/en not_active Abandoned
- 2005-12-29 BR BRPI0519622-1A patent/BRPI0519622A2/pt not_active IP Right Cessation
- 2005-12-29 WO PCT/EP2005/013530 patent/WO2006076951A1/en not_active Ceased
- 2005-12-29 EA EA200701525A patent/EA013969B1/ru not_active IP Right Cessation
2007
- 2007-07-23 NO NO20073850A patent/NO20073850L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE602005000675D1 (de)	2007-04-19
US20080206334A1 (en)	2008-08-28
KR20070100364A (ko)	2007-10-10
EP1685831B1 (en)	2007-03-07
ES2284088T3 (es)	2007-11-01
DE602005000675T2 (de)	2007-11-15
ZA200705660B (en)	2009-01-28
EA200701525A1 (ru)	2008-02-28
EP1685831A1 (en)	2006-08-02
BRPI0519622A2 (pt)	2009-02-25
WO2006076951A1 (en)	2006-07-27
ATE355833T1 (de)	2007-03-15
CA2592269A1 (en)	2006-07-27
CN101102756A (zh)	2008-01-09
EA013969B1 (ru)	2010-08-30
EP1838299A1 (en)	2007-10-03

Similar Documents

Publication	Publication Date	Title
EA200700049A1 (ru)	2007-04-27	Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
HRP20120264T1 (hr)	2012-04-30	Farmaceutski sastavi neuroaktivnog steroida i njihove uporabe
WO2007048219A3 (en)	2007-07-19	Sustained drug release composition
MX2009013832A (es)	2010-03-10	Derivados de purina y su uso como moduladores del receptor 7 similar a un puente.
MY157790A (en)	2016-07-29	Trazodone composition for once a day administration
EA200900087A1 (ru)	2009-06-30	Применение гидрофильной матрицы, содержащей производное полиакриловой кислоты, простой эфир целлюлозы и дезинтегрирующий агент, в производстве медикаментов для лечения заболеваний женских гениталий
NO20090141L (no)	2009-01-09	Stabiliserte, farmasøytiske preparater som omfatter fesoterodin
SG196810A1 (en)	2014-02-13	Controlled release pharmaceutical or foodformulation and process for its preparation
NO20065904L (no)	2007-02-20	Terapeutiske forbindelser
TW200716202A (en)	2007-05-01	Pediatric formulation of topiramate
DE602005025755D1 (de)	2011-02-17	Irbesartan enthaltende pharmazeutische zusammensetzung
CL2004000899A1 (es)	2005-03-04	Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
NO20062082L (no)	2006-05-09	Pellets inneholdende venlafaksinhydroklorid
MX2008010879A (es)	2008-10-27	Composiciones farmaceuticas de sodio de fluvastatina.
MY139086A (en)	2009-08-28	Use of debranched starch in extrusion-spheronization pharmaceutical pellets
EA201070806A1 (ru)	2010-12-30	Состав медленного высвобождения на основе ассоциации гликогена и альгината
WO2007017331A3 (en)	2007-09-27	Immediate release therapeutic systems for improved oral absorption of 7- [ (e) -tert-butyloxyiminomethyl] camptothecin
DE60319983D1 (de)	2008-05-08	Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
EA200701525A1 (ru)	2008-02-28	Фармацевтическая полимерная композиция для перорального введения тербуталина сульфата с контролируемым высвобождением
BRPI0506630A (pt)	2007-05-08	composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada
DE60219965D1 (de)	2007-06-14	Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
WO2009008004A3 (en)	2009-03-05	Sustained release formulations of divalproex sodium
UA94275C2 (ru)	2011-04-26	Фармацевтическая композиция, которая содержит по крайней мере один активный наркотический или психотропный компонент, назначенный способ введения которых в организм тяжело поддается изменению
JO2440B1 (en)	2008-10-09	Formulation of oral pharmaceutical polymers for controlled release of terbutalate sulfate.

Legal Events

Date	Code	Title	Description
2009-07-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application